Subtype
Malignant Colorectal Neoplasm
CI-CAN-00005874Explore in graph →
1,565 active trials21 approved drugs382 evidence items
- NCIt
- C4978
- DOID
- 9256
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005874Explore in graph →
Clinical trials
7,296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (722)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04941300 | ColoRectal Cancer Screening for Southern California Community Health Centers | completed | Phase 3 | 55,999 | University of California, San DiegoOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs(EARN) | completed | N/A | 33 | Washington University School of MedicineOTHER | 1 | Aug 26, 2025 | clinicaltrials |
| NCT03232541 | The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting | completed | N/A | 198 | Västernorrland County Council, SwedenOTHER_GOV | 1 | Aug 24, 2025 | clinicaltrials |
| NCT05873829 | Hand-Foot Exercises for Chemotheraphy Induced Peripheral Neuropathy Pain, Falls and Quality of Life in Colorectal Cancer | completed | N/A | 39 | Gulhane Training and Research HospitalOTHER_GOV | 1 | Aug 22, 2025 | clinicaltrials |
| NCT05259696 | Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)(GLIMMER-01) | completed | Phase 1 / Phase 2 | 69 | Palleon Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 20, 2025 | clinicaltrials |
| NCT05980182 | Engaging Black Men in Colorectal Cancer Screening(SUCCEED) | completed | N/A | 30 | Virginia Commonwealth UniversityOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT06185374 | Text Messaging to Improve Adherence To Repeat Colonoscopy In a Veterans Affairs (VA) Hospital | completed | N/A | 50 | NYU Langone HealthOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT04890054 | Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC(SMARTER CRC) | completed | N/A | 5,696 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT03277235 | Effect of a Resilience Model-Based Program for Patients With Newly Diagnosed Colorectal Cancer | completed | N/A | 128 | National Taiwan University HospitalOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT07125300 | A Study Comparing Standard and AI-Assisted Colonoscopies for Detecting and Characterizing Colorectal Lesions in Adults Aged 50-74 Undergoing Cancer Screening | completed | N/A | 368 | Javier Santos FernándezOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT02327078 | A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204) | completed | Phase 1 / Phase 2 | 307 | Incyte CorporationINDUSTRY | 2 | Aug 14, 2025 | clinicaltrials |
| NCT06314750 | Deep Learning Based MRI Radiomics in Predicting the Clinical Risk of Locally Advanced Rectal Cancer | completed | — | 186 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Aug 14, 2025 | clinicaltrials |
| NCT03314935 | A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors | completed | Phase 1 / Phase 2 | 149 | Incyte CorporationINDUSTRY | 3 | Aug 12, 2025 | clinicaltrials |
| NCT07084181 | Fitbit Assessed PS in Colorectal Cancer | completed | — | 80 | Fox Chase Cancer CenterOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT04825834 | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)(DELFI-L101) | completed | — | 2,992 | Delfi Diagnostics Inc.INDUSTRY | 2 | Aug 8, 2025 | clinicaltrials |
| NCT06424197 | Colorectal Cancer Screening Intervention Study | completed | N/A | 799 | Oakland UniversityOTHER | 1 | Aug 8, 2025 | clinicaltrials |
| NCT04311099 | Optimal Peripheral Nerve Block After Minimally Invasive Colon Surgery(OPMICS) | completed | Phase 4 | 360 | Claus Anders Bertelsen, PhD, MDOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT05585034 | Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors | completed | Phase 1 | 60 | Xencor, Inc.INDUSTRY | 1 | Aug 7, 2025 | clinicaltrials |
| NCT02903914 | Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors | completed | Phase 1 | 260 | Incyte CorporationINDUSTRY | 4 | Aug 5, 2025 | clinicaltrials |
| NCT07104903 | Risk Factor Assessment for the Development of Surgical Site Infection in Patients Undergoing Colorectal Cancer Surgery | completed | — | 62 | Oncology Institute of VojvodinaOTHER_GOV | 1 | Aug 5, 2025 | clinicaltrials |
| NCT03482362 | Vinorelbine in Advanced BRAF-like Colon Cancer(EORTC1616) | completed | Phase 2 | 1 | The Netherlands Cancer InstituteOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT05480306 | Phase 2 Study of DKN-01 in Colorectal Cancer(DeFianCe) | completed | Phase 2 | 188 | Leap Therapeutics, Inc.INDUSTRY | 3 | Aug 3, 2025 | clinicaltrials |
| NCT06048367 | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor(CNSI-Fe(II)) | completed | Phase 1 | 19 | Sichuan Enray Pharmaceutical Sciences CompanyOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT05292859 | Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs | completed | — | 7 | Alaunos TherapeuticsINDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT06980350 | Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy | completed | — | 156 | Sun Yat-sen UniversityOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT03199586 | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies | completed | Phase 1 | 23 | Novita Pharmaceuticals, Inc.INDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05090215 | Supervised Exercise for Post-surgery Colorectal Cancer Patients(POSTEx) | completed | N/A | 21 | University of NottinghamOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT05934643 | An Observational Cohort Study to Assess the Postop Activity of Colorectal Patients Undergoing Elective Surgery (PHYSPAL)(PHYSPAL) | completed | — | 17 | University of NottinghamOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06326437 | Dyadic Intervention for Psychological Distress of Patients With Colorectal Cancer and Their Spouses | completed | N/A | 90 | Sun Yat-sen UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT04826003 | Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment | completed | Phase 1 | 54 | Hoffmann-La RocheINDUSTRY | 5 | Jul 14, 2025 | clinicaltrials |
| NCT05940740 | Investigation of the Effect of Training on the Side Effects of Chemotherapy Given Via the Mobile Health Application on the Quality of Life in Colorectal Cancer Patients | completed | N/A | 70 | NESLISAH YASAR KARTALOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT06505863 | Quality of Life After Transanal Total Mesorectal Excision Compared to Traditional Total Mesorectal Excision | completed | — | 249 | Cantonal Hospital of St. GallenOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT04580485 | INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors | completed | Phase 1 | 54 | Incyte CorporationINDUSTRY | 6 | Jul 11, 2025 | clinicaltrials |
| NCT07059052 | Illness Perception and Quality of Life in Colorectal Cancer With Ascites | completed | — | 218 | Hebei Provincial Hospital of Traditional Chinese MedicineOTHER_GOV | 1 | Jul 10, 2025 | clinicaltrials |
| NCT02611024 | Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors | completed | Phase 1 / Phase 2 | 316 | PharmaMarINDUSTRY | 6 | Jul 9, 2025 | clinicaltrials |
| NCT02039336 | Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC(M13DAP) | completed | Phase 1 / Phase 2 | 35 | The Netherlands Cancer InstituteOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT02230553 | Lapatinib Plus Trametinib in KRAS Mutant NSCLC(M14LTK) | completed | Phase 1 / Phase 2 | 35 | The Netherlands Cancer InstituteOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT07049627 | AI-Based Prediction of Pathological Response in Rectal Cancer Patients Receiving Total Neoadjuvant Therapy(CINR-AI) | completed | — | 93 | Ankara Etlik City HospitalOTHER_GOV | 1 | Jul 8, 2025 | clinicaltrials |
| NCT00199862 | Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer | completed | N/A | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 4, 2025 | clinicaltrials |
| NCT02078726 | Glucagon Use in Colonoscopies | completed | Phase 4 | 100 | University of California, San FranciscoOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06314971 | Predicting Local and Distant Recurrence in T1 Colorectal Cancer(T1CR) | completed | — | 138 | City of Hope Medical CenterOTHER | 3 | Jul 3, 2025 | clinicaltrials |
| NCT07048847 | The Effect of Aerobic Exercise on Selective Biomarkers of Patients With Cancer | completed | — | 32 | Izmir Bakircay UniversityOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT02821793 | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer(PRIORITY) | completed | — | 346 | Institut BergoniéOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03442569 | PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC | completed | Phase 2 | 56 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03630354 | EXERCISING TOGETHER for Couples Coping With Cancer | completed | N/A | 496 | OHSU Knight Cancer InstituteOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT03186326 | Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer(SAMCO) | completed | Phase 2 | 132 | Federation Francophone de Cancerologie DigestiveOTHER | 1 | Jun 29, 2025 | clinicaltrials |
| NCT03584711 | FOLFOX + Panitumumab According to a "Stop and go" Strategy With a Reintroduction Loop After Progression on Fluoropyrimidine as Maintenance Treatment, as the First Line in Patients With Metastatic Colorectal Adenocarcinoma Without a RAS Mutation(OPTIPRIME) | completed | Phase 2 | 118 | Federation Francophone de Cancerologie DigestiveOTHER | 2 | Jun 29, 2025 | clinicaltrials |
| NCT03789162 | Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast | completed | — | 850 | Exact Sciences CorporationINDUSTRY | 2 | Jun 29, 2025 | clinicaltrials |
| NCT06414304 | Dynamics of MSI and Genomic Profile of Colorectal Cancer In the Course of Immune Checkpoint Inhibitor Therapy(BLOOMSI) | completed | — | 30 | OncoAtlas LLCINDUSTRY | 1 | Jun 27, 2025 | clinicaltrials |
| NCT05468827 | ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer(ISCAPE) | completed | N/A | 108 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | Jun 26, 2025 | clinicaltrials |
Data updated 23 days agoSource updated Aug 26, 2025source: clinicaltrials